Skip to main content
PMC home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1984 Oct;117(1):26–29.

The role of neutrophils in type II collagen-induced arthritis in rats.

D Schrier, R B Gilbertsen, M Lesch, J Fantone
PMCID: PMC1900570  PMID: 6333185

Abstract

Type II collagen-induced arthritis is a pathologic process mediated, in part, by humoral immune mechanisms. Because many antibody-mediated reactions are neutrophil-dependent, the role of this cell population was examined in collagen arthritis. In rats depleted of neutrophils with rabbit anti-rat neutrophil antiserum (ANS), swelling and inflammation associated with the arthritis response were maximally reduced by 65% (P less than 0.001). ANS treatment had no detectable effect on delayed hypersensitivity or antibody response to Type II collagen. Also, levels of peripheral blood monocytes, lymphocytes, and platelets were unaffected. Treatment with normal rabbit serum (NS) had no detectable effect on any of the inflammatory or immune parameters tested nor on circulating levels of monocytes, lymphocytes, or platelets. These results suggest that further study of the functions of neutrophils in rat collagen arthritis may be of help in our understanding of the role of this cell population in human arthritis.

Full text

PDF
26

Images in this article

28Figure 2
on p.28

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Clague R. B., Shaw M. J., Holt P. J. Incidence of serum antibodies to native type I and type II collagens in patients with inflammatory arthritis. Ann Rheum Dis. 1980 Jun;39(3):201–206. doi: 10.1136/ard.39.3.201. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Fantone J. C., Ward P. A. Role of oxygen-derived free radicals and metabolites in leukocyte-dependent inflammatory reactions. Am J Pathol. 1982 Jun;107(3):395–418. [PMC free article] [PubMed] [Google Scholar]
  3. Gosslau B., Barrach H. J. Enzyme-linked immunosorbent microassay for quantification of specific antibodies to collagen type I, II, III. J Immunol Methods. 1979;29(1):71–77. doi: 10.1016/0022-1759(79)90127-3. [DOI] [PubMed] [Google Scholar]
  4. Herbage D., Bouillet J., Bernengo J. C. Biochemical and physiochemical characterization of pepsin-solubilized type-II collagen from bovine articular cartilage. Biochem J. 1977 Feb 1;161(2):303–312. doi: 10.1042/bj1610303. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Oronsky A., Ignarro L., Perper R. Release of cartilage mucopolysaccharide-degrading neutral protease from human leukocytes. J Exp Med. 1973 Aug 1;138(2):461–472. doi: 10.1084/jem.138.2.461. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Phadke K., Carroll J., Nanda S. Effects of various anti-inflammatory drugs on type II collagen-induced arthritis in rats. Clin Exp Immunol. 1982 Mar;47(3):579–586. [PMC free article] [PubMed] [Google Scholar]
  7. Stuart J. M., Cremer M. A., Townes A. S., Kang A. H. Type II collagen-induced arthritis in rats. Passive transfer with serum and evidence that IgG anticollagen antibodies can cause arthritis. J Exp Med. 1982 Jan 1;155(1):1–16. doi: 10.1084/jem.155.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Trentham D. E., Dynesius R. A., David J. R. Passive transfer by cells of type II collagen-induced arthritis in rats. J Clin Invest. 1978 Aug;62(2):359–366. doi: 10.1172/JCI109136. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Trentham D. E., Dynesius R. A., Rocklin R. E., David J. R. Cellular sensitivity to collagen in rheumatoid arthritis. N Engl J Med. 1978 Aug 17;299(7):327–332. doi: 10.1056/NEJM197808172990703. [DOI] [PubMed] [Google Scholar]
  10. Trentham D. E., Townes A. S., Kang A. H. Autoimmunity to type II collagen an experimental model of arthritis. J Exp Med. 1977 Sep 1;146(3):857–868. doi: 10.1084/jem.146.3.857. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Trentham D. E., Townes A. S., Kang A. H., David J. R. Humoral and cellular sensitivity to collagen in type II collagen-induced arthritis in rats. J Clin Invest. 1978 Jan;61(1):89–96. doi: 10.1172/JCI108929. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. WARD P. A., COCHRANE C. G. BOUND COMPLEMENT AND IMMUNOLOGIC INJURY OF BLOOD VESSELS. J Exp Med. 1965 Feb 1;121:215–234. doi: 10.1084/jem.121.2.215. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Weissmann G. Activation of neutrophils and the lesions of rheumatoid arthritis. J Lab Clin Med. 1982 Sep;100(3):322–333. [PubMed] [Google Scholar]
  14. Weissmann G. Lysosomes and joint disease. Arthritis Rheum. 1966 Dec;9(6):834–840. doi: 10.1002/art.1780090611. [DOI] [PubMed] [Google Scholar]
  15. Zvaifler N. J. Further speculation on the pathogenesis of joint inflammation in rheumatoid arthritis. Arthritis Rheum. 1970 Nov-Dec;13(6):895–901. doi: 10.1002/art.1780130621. [DOI] [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES